Definium Therapeutics Inc (DFTX) PT Raised to $64 at Canaccord
Tweet Send to a Friend
(Updated - August 13, 2026 6:49 AM EDT)
Canaccord analyst Sumant Kulkarni raised the price target on Definium Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst Sumant Kulkarni raised the price target on Definium Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
